NEW CLINICAL GUIDELINES & FDA APPROVALS – APRIL 2022 ALERT

MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS? No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month.  CLINICAL GUIDELINES ACC/AHA/HFSA Management of Heart Failure (2022 Update) ASCO Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer Biomarkers for […]